DUBLIN, IRELAND--(Marketwired - Sep 22, 2014) - Horizon Pharma plc (
The presentation will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com . A replay of the webcast will be available for 10 business days.
About Horizon Pharma plc Horizon Pharma plc is a specialty biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated products that address unmet medical needs. The company markets a portfolio of products in arthritis, inflammation and orphan diseases. The company's U.S. marketed products are ACTIMMUNE ® (interferon gamma-1b), DUEXIS ® (ibuprofen/famotidine), RAYOS ® (prednisone) delayed-release tablets and VIMOVO ® (naproxen/esomeprazole). Horizon's global headquarters are in Dublin, Ireland. For more information, please visit www.horizonpharma.com .
Contact Elizabeth M. Higashi, CFA Vice President, Investor Relations Email Contact